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Myelin and oligodendrocyte disruptionmay be a core feature of schizophrenia pathophysiol-
ogy.The purpose of the present studywas to localize the effects of previously identiﬁed risk
variants in the myelin-associated glycoprotein (MAG) gene on brain morphometry in schiz-
ophrenia patients and healthy controls. Forty-ﬁve schizophrenia patients and 47 matched
healthy controls underwent clinical, structural magnetic resonance imaging, and genetics
procedures. Gray and white matter cortical lobe volumes along with hippocampal volumes
were calculated from T1-weighted MRI scans. Each subject was also genotyped for the
two disease-associated MAG single nucleotide polymorphisms (rs720308 and rs720309).
Repeated measures general linear model (GLM) analysis found signiﬁcant region by geno-
type and region by genotype by diagnosis interactions for the effects of MAG risk variants
on lobar gray matter volumes. No signiﬁcant associations were found with lobar white
matter volumes or hippocampal volumes. Follow-up univariate GLMs found the AA geno-
type of rs720308 predisposed schizophrenia patients to left temporal and parietal gray
matter volume deﬁcits.These results suggest that the effects of the MAG gene on cortical
gray matter volume in schizophrenia patients can be localized to temporal and parietal
cortices. Our results support a role for MAG gene variation in brain morphometry in
schizophrenia, align with other lines of evidence implicating MAG in schizophrenia, and
provide genetically based insight into the heterogeneity of brain imaging ﬁndings in this
disorder.
Keywords: schizophrenia, myelin-associated glycoprotein, imaging–genetics, temporal lobe, parietal lobe, gray
matter volume
INTRODUCTION
Changes in myelin- and oligodendrocyte-related genes have been
implicated in the pathophysiology of schizophrenia. Postmortem
studies of multiple brain regions show dysregulation of myelin-
associated genes in schizophrenia (Fannon et al., 2000;Hakak et al.,
2001; Aston et al., 2004; Katsel et al., 2005; Haroutunian et al.,
2007) and of these, the myelin-associated glycoprotein (MAG)
gene is consistently among the most down-regulated. Addition-
ally, two candidate gene studies have found associations of MAG
variants with schizophrenia: Yang et al. (2005), in a transmission
disequilibrium test (TDT) analysis of 413ChineseHan trios, found
positive associations with two-marker haplotypes of rs720308 and
rs720309, and Wan et al. (2005), using a case–control design
(ncase = 470, ncontrol = 470, also Chinese Han), found the same
markers signiﬁcantly associatedwith schizophrenia.More recently,
we found a signiﬁcant association between MAG genotype at these
same loci and total cortical gray matter volume in ﬁrst episode
schizophrenia patients (Voineskos et al., 2008), however, no study
has yet examined the regional effects of these SNPs on the brain.
Brain matter abnormalities in the frontal and temporal cortices
are among the most common ﬁndings in neuroimaging stud-
ies of schizophrenia (Fornito et al., 2009; Shenton et al., 2010).
Structural analyses of brain changes in schizophrenia have prin-
cipally found volume deﬁcits in the superior temporal gyrus as
well as medial temporal lobe structures, such as the hippocampus
and parahippocampal gyrus (Shenton et al., 2010). Abnormalities
of the prefrontal cortex have also been identiﬁed in schizophrenia
(Shenton et al., 2010). Disruptions of the parietal and occipital
lobes, though less studied than other brain regions in schizophre-
nia, may also be features of this disease. Schlaepfer et al. (1994)
and Ross and Pearlson (1996) have demonstrated reductions in
gray matter of the heteromodal association cortex, which includes
the inferior parietal lobule, in schizophrenia patients.
Biologically convergent lines of evidence have independently
implicated MAG locus variation and cortical gray matter volume
deﬁcits as potential schizophrenia liability factors. The present
study builds on our previous association of MAG with total corti-
cal gray matter volume in schizophrenia by analyzing the effect of
MAG genotype on regional cortical brain gray and white matter
volumes. We also examined effects of genotype on the hippocam-
pus since there is evidence for altered MAG regulation in schiz-
ophrenia in this region (Dracheva et al., 2006). We hypothesized,
based on postmortem data and our previous work, that MAG
genotype would predict variation in cortical gray matter volumes,
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particularly in frontal and temporal brain regions. Furthermore,
given altered expression of the MAG gene in schizophrenia, as
well as our previous ﬁndings of reduced cortical gray mater in
schizophrenia patients only, we hypothesized that there may be
a genotype by diagnosis interaction predicting variation in brain
imaging measures.
MATERIALS AND METHODS
SAMPLE SELECTION
Study participants were recruited at the Centre for Addiction and
Mental Health (CAMH) in Toronto, Canada by referral, study
registries, and advertisements. To characterize clinical symptoms,
participants were administered the structured clinical interview
for DSM-IV disorders (SCID; First et al., 1995) and the positive
and negative syndrome scale (PANSS), and were interviewed by
a psychiatrist at CAMH to ensure diagnostic accuracy. Details
on history of medication were gathered by self-report and veri-
ﬁed when necessary by the treating psychiatrist and chart review.
All participants were Caucasian and between 18 and 59 years of
age. Exclusion criteria for patients included any history of sub-
stance dependence or abuse within the past 6 months, previous
head trauma, loss of consciousness, and neurological disorders.
For controls, additional exclusion criteria included any history of a
primary psychotic disorder in ﬁrst-degree relatives. Controls were
group matched to patients based on age, gender, and handedness
(Edinburgh handedness inventory; Oldﬁeld, 1971). Written and
informed consent was obtained and the study was approved by
the CAMH Ethics Review Board.
GENOTYPING
Subjects were genotyped for two SNPs at theMAG locus (rs720308
and rs720309). DNA was extracted from blood samples using a
modiﬁed high-salt method (Lahiri and Nurnberger, 1991), and
checked for concentration using the NanoDrop 8000 spectropho-
tometer. Samples were deemed acceptable if their concentration
was>0.02μg/μl andoptical density (OD)A260/280 ratio between
1.5 and 2.5. Samples were then diluted to a ﬁnal concentration of
20 ng/μl for genotype analysis. Genotyping was done using the
Taqman Assay-on-Demand protocol with a total PCR reaction
volume of 10μl. Markers were analyzed post-ampliﬁcation using
the Applied Biosystems 7500 Real-Time PCR System for allelic
discrimination, and calls were made manually. Two lab personnel
independently veriﬁed results and 10% of sample genotypes were
duplicated for quality control.
IMAGE ACQUISITION
High resolution magnetic resonance images were acquired as part
of a multi-modal imaging protocol using an eight-channel head
coil on a 1.5-T GE Echospeed system (General Electric Medical
Systems,Milwaukee,WI,USA),which permits maximum gradient
amplitudes of 40 mT/m.Axial inversion recovery prepared spoiled
gradient recall images were acquired: echo time (TE)= 5.3 ms,
repetition time (TR) = 12.3 ms, time to inversion (TI)= 300 ms,
ﬂip angle= 20˚, number of excitations (NEX) = 1 (124 contiguous
images, 1.5 mm thickness).
IMAGE PROCESSING
For cortical volume analysis, each subject’s T1 image was
submitted to the CIVET pipeline (version 1.1.7 developed at the
Montreal Neurologic Institute; Ad-Dab’bagh et al., 2006). The
processing steps included registration to the symmetric ICBM
152 template (Mazziotta et al., 2001) with a 12-parameter lin-
ear transformation (Collins, 1994), correction for inhomogeneity
artifact (Sled et al., 1998), skull stripping (Smith et al., 2002), tissue
classiﬁcation into white and gray matter, cerebrospinal ﬂuid and
background (Zijdenbos et al., 2002; Tohka et al., 2004), and neu-
roanatomical segmentation using ANIMAL (Collins et al., 1995).
Total volumes for each cortical lobe were estimated for each indi-
vidual by non-linearly warping each T1 image toward a segmented
atlas. Volume (mm3) was extracted from each of these regions
using the RMINC package (version 0.4) for reading and ana-
lyzing MINC2 output ﬁles. Total gray matter, white matter, and
CSF volumes were calculated, along with lobar cortical gray and
whitematter volumes (i.e., left and right frontal, temporal,parietal,
occipital).
For hippocampal volumes, each individual’s T1-weighted
image was processed using the FMRIB’s Integrated Registra-
tion and Segmentation Tool (FIRST v1.2) automated subcor-
tical segmentation pipeline (Patenaude, 2007; Patenaude et al.,
2011) included in the open access FSL (v.4.1.8) package. This
method uses a Bayesian modeling framework based on multivari-
ate Gaussian assumptions to estimate the shape and appearance
of subcortical structures. To achieve this, it employs point dis-
tribution and surface mesh models generated from a set of 336
manually segmented images (provided by the Centre for Mor-
phometric Analysis (CMA), MGH, Boston). Each subject’s image
was registered using FLIRT (Jenkinson et al., 2002) in a two-step
transformation (each step using 12 degrees of freedom) that ﬁrst
afﬁne-registered whole-head images to non-linear MNI152 space
(1 mm resolution) and then excluded voxels outside a subcortical
mask (generated from the ﬁlled average shapes of all subcortical
structures being segmented in theMNI space). The automated seg-
mentation process then computed themost probable shape of each
structure by comparing linear combinations of shape principal
components from themanually segmentedmodels to the observed
intensities from each input image. The resulting vertex models
were then transformed back to native space, boundaries corrected,
and volumes were calculated for left and right hippocampus.
Brain tissue volume, normalized for subject head size, was esti-
mated with SIENAX (Smith et al., 2001; Smith, 2002), also part
of the FSL toolkit. First, brain and skull images were extracted
from the single whole-head images (Smith, 2002) and then afﬁne-
registered to MNI152 space (Jenkinson and Smith, 2001) (using
the skull image to determine registration scaling). Next, tissue-
type segmentation with partial volume estimation was carried out
(Zhang et al., 2001) in order to calculate total volume of brain
tissue (including separate volume estimates of gray matter, white
matter, peripheral gray matter, and ventricular CSF).
STATISTICAL ANALYSIS
Statistical packages for the social sciences (SPSS) version 19 was
used for statistical analysis. Individuals were grouped by genotype
at rs720308 and rs720309 as eithermajor allele (A/T) homozygotes
or minor allele (G/A) carriers and a repeated measures general lin-
ear model (GLM) was applied. Separate analyses were carried out
for lobar gray and white matter measures. For each cortical analy-
sis, genotype and diagnosis were between-group factors, and eight
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within-group factors corresponding to left and right frontal, tem-
poral, parietal, and occipital lobe volumes were used, with age and
total brain volume as covariates. For hippocampal volume, a sepa-
rate repeatedmeasures analysis with twowithin-group factors (left
and right hippocampus) was applied to determine effects of diag-
nosis and genotype, with total brain volume and age as covariates.
Where repeatedmeasures analyses showed signiﬁcant associations,
post hoc univariate GLM analysis was used to localize effects of
genotype and/or diagnosis on brain morphometry measures.
RESULTS
A 100% successful genotyping rate was achieved. MAG genotype
distribution was not signiﬁcantly different between schizophrenia
patients and controls and did not violate Hardy–Weinberg equi-
librium (p = 0.578). The SNPs under investigation were in full
linkage disequilibrium (D′ = 1) in this sample. Therefore, we pro-
ceeded with imaging–genetics analysis using only one of the two
SNPs (we chose rs720308). There were no signiﬁcant differences
in gender (p = 0.503), age (p = 0.137), or ethnicity (all Caucasian)
between the group of schizophrenia patients (n = 45) and controls
(n = 47; Table 1).
RepeatedmeasuresGLMfounda signiﬁcant regionby genotype
interaction (F7,602 = 2.8, p = 0.007, Greenhouse–Geisser correc-
tion: F4,317 = 2.8, p = 0.031) and signiﬁcant region by genotype
by diagnosis interaction (F7,602 = 3.2, p = 0.003, Greenhouse–
Geisser correction: F4,317 = 3.2, p = 0.016) for lobar gray matter
volumes. No signiﬁcant associations were found with lobar white
matter volumes (Genotype by region: F7,602 = 0.45, p = 0.87;
genotype by region by diagnosis: F7,602 = 1.6, p = 0.12) or hip-
pocampal volumes (Genotype by region: F1,86 = 0.21, p = 0.65;
genotype by region by diagnosis: F1,86 = 2.43, p = 0.12).
Follow-up univariate GLM on bilateral lobar gray matter vol-
umes found a main effect of diagnosis for frontal lobe volume
(F5,86 = 5.361, p = 0.023), a main effect of genotype for temporal
lobe volume (F5,86 = 7.318, p = 0.008), and a signiﬁcant genotype
by diagnosis interaction for parietal lobe volume (F5,86 = 6.478,
p = 0.0127). However, after Bonferroni correction for four com-
parisons (p = 0.0125), only the temporal lobe ﬁnding remains
signiﬁcant, with the parietal lobe bordering on signiﬁcance.
Further investigation of left and right hemispheres localized
the temporal and parietal ﬁndings to the left side (F = 7.742,
p = 0.007 and F = 7.930, p = 0.006, respectively), with analyses
of the right temporal and parietal lobes failing to survive correc-
tion for multiple comparisons (F = 4.852, p = 0.03 and F = 3.245,
p = 0.075, respectively). TheAA genotype predisposed both schiz-
ophrenia patients and healthy controls to lower left temporal
gray matter volume (Figure 1). In addition, this genotype pre-
disposed schizophrenia patients to lower left parietal gray matter
volume (Figure 2). Chlorpromazine (CPZ) equivalents of med-
ication exposure (mg/day) were calculated for the schizophrenia
patients (mean= 361, SD= 318) and regressed against lobar vol-
umetric measures. No signiﬁcant correlation of CPZ equivalents
was found with any lobar brain measure.
DISCUSSION
The present study used a carefully matched sample of schizophre-
nia patients and healthy controls to examine the effects of putative
MAG gene risk variants on brain morphometry. Our main ﬁnd-
ings were that variation in theMAG gene inﬂuenced temporal lobe
gray matter volume in both schizophrenia patients and healthy
controls, and left parietal lobe gray matter volume in schizophre-
nia patients. Our ﬁndings localize previously shown effects of
the MAG gene on cortical gray matter to temporal and parietal
regions. No association of this locus with white matter volumes or
hippocampus was found.
Myelin system genes may play a key role in cortical brain
growth, development, and maintenance, as these genes are critical
in oligodendrocyte growth, maintenance, and repair during the
Table 1 | Sample demographics information including p-value of group difference between controls and schizophrenics.
Demographic Controls (n=47), mean (SD) Schizophrenics (n=45), mean (SD) Difference (p)
Age 38(13) 42(14) 0.137
Education 16(2) 13(3) <0.001
WTAR (IQ) 118(8) 110(16) 0.002
MMSE 29(1) 29(1) 0.144
CIRS-G 0.6(0.6) 2(0.6) <0.001
Chlorpromazine equivalent (mg/day) NA 361(318) NA
PANSS
Positive NA 14(5) NA
Negative NA 15(6) NA
General NA 26(7) NA
Total NA 55(16) NA
Gender 13 F, 34 M 16 F, 29 M 0.503
Antipsychotic treatment NA 2 1˚, 35 2˚, 2, none, 6 NA
Age, Education, WTAR, MMSE, and CIRS-G differences were assessed using independent sample t-tests, and Gender differences were assessed using Fisher’s
exact test.
NA, not applicable; M, male; F, female; WTAR, Wechsler Test for Adult Reading; MMSE, Mini Mental State Examination; CIRS-G, Clinical Information Rating Scale,
Geriatrics.
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* *
FIGURE 1 | Estimated marginal means of gray matter volume in the
temporal lobe, by diagnosis and genotype at MAG rs720308, adjusted
for age and total brain volume. Genotype effect (F =7.742, p =0.007) is
shown for left hemisphere. (HC, healthy controls, SCZ, schizophrenic
patients).
*
FIGURE 2 | Estimated marginal means of gray matter volume in the
parietal lobe, by diagnosis and genotype at MAG rs720308, adjusted
for age and total brain volume. Genotype by diagnosis interaction
(F =7.930, p =0.006) is shown for left hemisphere. (HC, healthy controls,
SCZ, schizophrenic patients).
adult lifespan. The MAG gene speciﬁcally supports axon stability
and impulse transmission through its maintenance of the inter-
membrane distance of the periaxonal space (Nguyen et al., 2009).
Considerable evidence points to abnormalities in expression of
the MAG gene in the temporal lobe in schizophrenia (Hakak et al.,
2001; Katsel et al., 2005; Haroutunian et al., 2007), aligning with
temporal lobe volume reductions in this disorder. Furthermore,
temporal lobe volume deﬁcits in the left hemisphere are reported
more frequently than those in the right (Sun et al., 2009).Our ﬁnd-
ing of MAG gene variation inﬂuence on left temporal lobe volume
in healthy controls may represent an intermediate risk phenotype
for schizophrenia. In schizophrenia patients, it is possible that the
MAG rs720308AAgenotype could predict risk for poorer outcome
or decreased cognitive reserve based on its effects on left temporal
lobe volume. At the same time, effects of the MAG gene on left
temporal volume may help explain heterogeneity of ﬁndings in
neuroimaging studies of the temporal lobe in schizophrenia.
We found that MAG genotype interacted with diagnosis to
predict gray matter volume in the parietal lobe. Dysfunction of
the parietal lobe may play a critical role in schizophrenia patho-
physiology, as it is a key functional domain for many cognitive
processes commonly affected in schizophrenia (Torrey, 2007).
Compared to the temporal lobe, far fewer reports of parietal lobe
volume postmortem or in vivo with MRI have been published
in schizophrenia. Those examining parietal tissue have focused
on Brodmann area 7 and found dysregulation of several genes
involved in apoptotic pathways and nerve maturation, but not of
MAG itself (Katsel et al., 2005; Haroutunian et al., 2007). Nev-
ertheless, our ﬁnding here provides an intriguing potential role
for MAG gene variation in parietal lobe volume in schizophre-
nia. Similar to the heterogeneity in temporal lobe ﬁndings, MAG
gene variation may provide one explanation for heterogeneity of
parietal lobe ﬁndings in schizophrenia. A challenge in studying
the parietal lobe is its anatomical variability, making it a difﬁ-
cult region to parcellate effectively. Furthermore, the histological
division of inferior parietal structures, namely the angular and
supramarginal gyri (Brodmann areas 39 and 40, respectively), has
been reevaluated and seven distinct cytoarchitectonic areas identi-
ﬁed using an observer-independent method (Caspers et al., 2006).
With the advent of superior neuroanatomical parcelation meth-
ods in neuroimaging, future work might be able to examine the
inﬂuence of MAG genotype in these more specialized regions.
Several potential biological mechanisms may explain the
observed effects of MAG gene variation on brain morphology.
First, variation in the MAG gene could potentially be responsible
for the lower levels of MAG observed in postmortem schizophre-
nia brain. Second, regional differences of MAG expression may be
responsible for myelin abnormalities that have been implicated in
a number of demyelinating diseases bearing symptomatic congru-
ency to schizophrenia (Davis et al., 2003). Myelin abnormalities
have also been shown to result in axonal degeneration and a reduc-
tion in connectivity (Stewart and Davis, 2004), key elements of the
myelin–oligodendrocyte hypothesis of schizophrenia pathology.
Third, the effects of MAG on gray matter may occur indirectly.
The MAG knockout mouse shows reduced density of pyramidal
cell basal dendrites of the prefrontal cortex (Segal et al., 2007).
Lack of MAG expression, and subsequent effects on other myelin
system genes, could affect the ability of satellite oligodendrocytes
(in gray matter) to support surrounding neurons (Baumann and
Pham-Dinh, 2001). Finally, genetic variation in MAG may inﬂu-
ence axonal organization and sprouting since MAG acts as part
of a myelin-mediated complex that functions to inhibit axonal
growth (Voineskos, 2009). This complex consists of several pro-
teins encoded for by myelin related genes, including the MAG
gene, the myelin–oligodendrocyte glycoprotein (MOG) gene, and
the receptor tyrosine kinase erbB3 (ErbB3) gene,which bind to the
Nogo-66 receptor (gene located in the 22q11 chromosomal region;
Budel et al., 2008). Recent data supports that this complexmayplay
a role in the etiopathogenesis of schizophrenia (Budel et al., 2008).
TheMAG gene transcript is known toundergo alternative splic-
ing and it is possible that the intronic SNPs investigated here
may play a role in this process, though molecular studies will be
needed to identify the functional effect of variation at these loci.An
exploratory in silico analysis [using the online TFSEARCH search
tool (Akiyama; Heinemeyer et al., 1998)] of potential transcrip-
tion factor (TF) binding sites at these loci has found a decrease in
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binding potential of the sex-determining region Y (SRY ) protein
predicted by the rs720309 T allele (corresponding to the rs720308
A allele). Interestingly, this male-speciﬁc TF is highly expressed in
the brain and involved in the biochemical regulation of dopamin-
ergic neurons of the nigrostriatal system (Dewing et al., 2006).
Although this raises the possibility of sex interactions, we have an
insufﬁcient sample size to test such a hypothesis here. Addition-
ally, it should be noted that these SNPs are not near the promoter
region of the MAG gene – leaving the possibility of distal enhancer
effects of this TF on MAG expression.
There are several limitations that should be considered in this
study. First, as in any structural neuroimaging investigation, par-
tial volume effects can lead to misclassiﬁcation of tissue. Second,
while it is possible that our association is a false positive result, the
fact that the present ﬁnding is in the same direction as our pre-
vious MAG imaging–genetics result on total cortical gray matter
volume reduces this concern. Third, newer imaging techniques for
evaluating white matter may reveal associations with MAG gene
variants. We are addressing this as part of our ongoing studies.
Finally, medication effects on brain volumes cannot be ruled out,
despite the fact that no relationship with chlorpromazine equiv-
alent dose was found. Our previous ﬁnding of association of this
variant with cortical gray matter volume in a largely unmedicated,
ﬁrst episode schizophrenia sample (Voineskos et al., 2008) should
also help alleviate concerns regarding this potential confound.
In conclusion, we have identiﬁed that variation in the MAG
gene inﬂuences temporal gray matter volumes in healthy con-
trols and chronic schizophrenia patients, and parietal gray matter
volumes in schizophrenia patients only. Our ﬁndings highlight a
potential risk mechanism for temporal lobe volume reduction in
schizophrenia via variation at the MAG gene, and that heterogene-
ity in structural neuroimaging ﬁndings in schizophrenia may be
in part due to genetic variation in a given sample. Furthermore,
the MAG gene variants may help parse out molecular subtypes of
schizophrenia that could have important implications for treat-
ment decisions in the future. Overall, our ﬁndings highlight the
importance of MAG gene variation in brain morphometry in
schizophrenia.
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